Crescent Biopharma Statistics

Total Valuation

CBIO has a market cap or net worth of $242.03 million. The enterprise value is $244.15 million.

Market Cap	242.03M
Enterprise Value	244.15M

Important Dates

The next estimated earnings date is Sunday, November 23, 2025, after market close.

Earnings Date	Nov 23, 2025
Ex-Dividend Date	n/a

Share Statistics

CBIO has 19.55 million shares outstanding.

Current Share Class	13.89M
Shares Outstanding	19.55M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+2,273.50%
Owned by Insiders (%)	0.60%
Owned by Institutions (%)	39.25%
Float	6.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.62

Current Ratio	3.62
Quick Ratio	3.62
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-20.18

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-264.45%
Revenue Per Employee	n/a
Profits Per Employee	-$11.91M
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	12.83
200-Day Moving Average	n/a
Relative Strength Index (RSI)	52.29
Average Volume (20 Days)	151,743

Short Selling Information

The latest short interest is 502,379, so 2.57% of the outstanding shares have been sold short.

Short Interest	502,379
Short Previous Month	261,915
Short % of Shares Out	2.57%
Short % of Float	8.27%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-68.76M
Pretax Income	-71.47M
Net Income	-71.47M
EBITDA	n/a
EBIT	-68.76M
Earnings Per Share (EPS)	-$13.45

Full Income Statement

Balance Sheet

The company has $34.77 million in cash and $37.48 million in debt, giving a net cash position of -$2.72 million or -$0.14 per share.

Cash & Cash Equivalents	34.77M
Total Debt	37.48M
Net Cash	-2.72M
Net Cash Per Share	-$0.14
Equity (Book Value)	-11.48M
Book Value Per Share	-2.20
Working Capital	25.19M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-25.08M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-29.60%
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for CBIO is $25.60, which is 106.79% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$25.60
Price Target Difference	106.79%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1